Tiotropium and salmeterol xinafoate and fluticasone propionate powder for inhalation combined with non-invasive ventilation in respiratory failure
10.3969/j.issn.1005-1678.2017.03.055
- VernacularTitle:噻托溴铵和沙美特罗替卡松粉吸入剂联合无创呼吸机治疗呼吸衰竭患者的临床研究
- Author:
Jinming XU
;
Feng LI
;
Wei CHEN
- Keywords:
tiotropium;
salmeterol xinafoate and fluticasone propionate powder for inhalation;
non-invasive ventilator;
respiratory failure
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(3):181-183
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the clinical efficacy of tiotropium and salmeterol xinafoate and fluticasone propionate powder for inhalation combined with noninvasive ventilator in the treatment of respiratory failure, and to provide reference for clinical treatment.Methods 72 patients with respiratory failure were randomly divided into treatment group (n=36) and control group (n=36).The patients were randomly divided into treatment group and control group.Patients in the control group were treated with conventional noninvasive ventilators and treatment group were treated with tiotropium and salmeterol xinafoate and fluticasone propionate powder for inhalation on the basis of control group.Then compare the exercise tolerance, arterial carbon dioxide partial pressure, heart rate, pH, respiratory rate, blood oxygen pressure between two groups.Results After the treatment, condition of the patients in the two groups have different degrees of improvement.The final results showed that the average hospital stay was significantly reduced, respiratory frequency was(28 ±5) times/min in treatment group, heart rate was(98 ±16) times per minute, PaO2 also increased to(72 ±3) mmHg, PaCO2 was(57 ±17) mmHg, pH value increased to (7.42 ±0.03), compared with the control group, with statistically significant difference (P<0.05).Conclusion In patients with clinical implementation of tiotropium and seretide combined with non-invasive ventilator treatment of respiratory failure, can significantly improve the patient's condition, so that patients with respiratory function was significantly improved, so that the indicators of patients tend to normal.Its can effectively reduce PaCO2 , increased PaO2 and speed up its cure rate.
